First Horizon Advisors, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

First Horizon Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$0.28 - $1.16 $630 - $2,611	-2,251 Reduced 6.89%	30,398 $10,000
Q1 2024 Apr 26, 2024	BUY	$1.06 - $1.67 $5,386 - $8,486	5,082 Added 18.44%	32,649 $37,000
Q4 2023 Feb 06, 2024	BUY	$1.26 - $1.79 $4,023 - $5,715	3,193 Added 13.1%	27,567 $46,000
Q3 2023 Oct 27, 2023	SELL	$1.61 - $2.54 $12,152 - $19,171	-7,548 Reduced 23.65%	24,374 $44,000
Q2 2023 Aug 03, 2023	BUY	$1.14 - $1.95 $5,287 - $9,044	4,638 Added 17.0%	31,922 $59,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $8,062 - $14,714	6,719 Added 32.67%	27,284 $36,000
Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $2,267 - $4,896	1,391 Added 7.25%	20,565 $34,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $2,106 - $10,793	2,886 Added 17.72%	19,174 $59,000
Q2 2022 Aug 02, 2022	BUY	$2.2 - $4.2 $35,833 - $68,409	16,288 New	16,288 $38,000

209

716M

990K

2.23M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.3B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.